Previous studies have identified LINC01554 as a liver-enriched tumor suppressor lncRNA that regulates glucose metabolism by promoting PKM2 degradation and inhibiting the Akt/mTOR pathway, thereby suppressing HCC progression [41]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.